Overview

Botulinum Toxin Type A for Cold Intolerance Secondary to Digital Amputations and Replantations: A Pilot Study

Status:
Enrolling by invitation

Trial end date:
2022-06-02

Target enrollment:

Participant gender:

Summary

Patients will be selected for cold intolerance after finger amputation or replantation. They will be given Botox or placebo dose as treatment and assessed over 3 months.

Phase:

Phase 1

Details

Lead Sponsor:

Massachusetts General Hospital

Collaborator:

Allergan